NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open1,500
High1,512.7
Low1,500
Prev. Close1,511.4
Avg. Traded Price1,505.14
Volume1,30,835
MARKET DEPTH
Total bid1,03,846.00
Total ask1,00,747.00
| Orders | Qty | Bid |
|---|
| 5 | 254 | 1504.2 |
| 2 | 7 | 1504.1 |
| 8 | 110 | 1504 |
| 3 | 336 | 1503.9 |
| 4 | 361 | 1503.8 |
| Ask | Qty | Orders |
|---|
| 1504.3 | 1 | 16 |
| 1504.4 | 1 | 21 |
| 1504.5 | 7 | 303 |
| 1504.7 | 4 | 241 |
| 1504.8 | 3 | 100 |
HIGH/LOW
LOW/HIGH
₹1,499.40a minute ago
₹1,512.7019 minutes ago
UTI Healthcare Fund-Reg(IDCW)
3Y Return+21.7%
NAV₹209.72
3Y Return+19.4%
NAV₹160.63
UTI Multi Asset Allocation Fund-Reg(G)
UTI Dividend Yield Fund-Reg(G)
3Y Return+18.6%
NAV₹168.82
LIC MF Healthcare Fund-Reg(G)
Cipla Limited, established in 1935, is a global pharmaceutical company with a strong commitment to make medicines accessible and affordable to those in need. The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS and various other key therapeutic segments. With a rich portfolio, the company is deepening its presence in the home markets of India, as well as South Africa, North America and other key regulated and emerging markets.
